CD27/CFSE-based ex vivo selection of highly suppressive alloantigen-specific human regulatory T cells

Journal of Immunology

Volumn 174, Issue 12, 2005, Pages 7573-7583

  Koenen, Hans J P M ^a   Fasse, Esther ^a   Joosten, Irma ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; ANTIGEN; CD27 ANTIGEN; CD4 ANTIGEN; CFSE ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGY; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CELL SORTER; CONTROLLED STUDY; EX VIVO STUDY; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOTHERAPY; LYMPHOCYTE CULTURE; MEMORY CELL; MIXED LYMPHOCYTE CULTURE; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TREG BASED IMMUNOTHERAPY;

EID: 20444374502     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.12.7573     Document Type: Article

References (51)

1. Maloy, K. J., and F. Powrie. 2001. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2: 816-822.
2. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2: 389-400.
3. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199: 971-979.
4. + regulatory T cells in autoimmune polyglandular syndrome type II. J. Exp. Med. 199: 1285-1291.
5. Ehrenstein, M. R., J. G. Evans, A. Singh, S. Moore, G. Warnes, D. A. Isenberg, and C. Mauri. 2004. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J. Exp. Med. 200: 277-285.
6. + regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 363: 608-615.
7. + HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200: 331-343.
8. + regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. 196: 389-399.
9. + immunoregulatory T cells: new therapeutics for graft-versus-host disease. J. Exp. Med. 196: 401-406.
10. + immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99: 3493-3499.
11. + regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin. Invest. 112: 1688-1696.
12. + T lymphocytes. Blood 103: 4216-4221.
13. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199: 1467-1477.
14. Tang, Q., K. J. Henriksen, M. Bi, E. B. Finger, G. Szot, J. Ye, E. L. Masteller, H. McDevitt, M. Bonyhadi, and J. A. Bluestone. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199: 1455-1465.
15. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193: 1285-1294.
16. + T cells with regulatory properties from human blood. J. Exp. Med. 193: 1303-1310.
17. + cells: a naturally occurring population of regulatory T cells. Blood 98: 2736-2744.
18. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 164: 183-190.
19. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296.
20. + regulatory T cells. Eur. J. Immunol. 32: 1621-1630.
21. high regulatory T cells. Blood 104: 895-903.
22. + T helper cells. J. Exp. Med. 196: 255-260.
23. Chen, Y., V. K. Kuchroo, J. Inobe, D. A. Hafler, and H. L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237-1240.
24. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742.
25. - regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168: 1080-1086.
26. Roncarolo, M. G., R. Bacchetta, C. Bordignon, S. Narula, and M. K. Levings. 2001. Type 1 T regulatory cells. Immunol. Rev. 182: 68-79.
27. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192: 295-302.
28. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192: 303-310.
29. + regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA 99: 8213-8218.
30. + regulatory T cells ex vivo. Blood 102: 2180-2186.
31. + T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 104: 453-461.
32. + T cells that require antigen-specific activation for suppression. J. Immunol. 171: 6431-6441.
33. + regulatory T cells. Nat. Immunol. 4: 330-336.
34. + T regulatory cells. Nat. Immunol. 4: 337-342.
35. +. J. Clin. Invest. 112: 1437-1443.
36. Godfrey, W. R., M. R. Krampf, P. A. Taylor, and B. R. Blazar. 2004. Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation. Blood 103: 1158-1165.
37. + t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193: 1295-1302.
38. high regulatory cells in human peripheral blood. J. Immunol. 167: 1245-1253.
39. - regulatory cells mediate dominant transplantation tolerance. J. Immunol. 168: 5558-5565.
40. + and. J. Immunol. 165: 3105-3110.
41. + as well as. Proc. Natl. Acad. Sci. USA 99: 13031-13036.
42. + regulatory T cells in the steady state. J. Exp. Med. 198: 737-746.
43. Arens, R., K. Tesselaar, P. A. Baars, G. M. van Schijndel, J. Hendriks, S. T. Pals, P. Krimpenfort, J. Borst, M. H. van Oers, and R. A. van Lier. 2001. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNγ-mediated B cell depletion. Immunity 15: 801-812.
44. Hendriks, J., L. A. Gravestein, K. Tesselaar, R. A. van Lier, T. N. Schumacher, and J. Borst. 2000. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1: 433-440.
45. Hendriks, J., Y. Xiao, and J. Borst. 2003. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J. Exp. Med. 198: 1369-1380.
46. Guinan, E. C., V. A. Boussiotis, D. Neuberg, L. L. Brennan, N. Hirano, L. M. Nadler, and J. G. Gribben. 1999. Transplantation of anergic histoincompatible bone marrow allografts. N. Engl. J. Med. 340: 1704-1714.
47. Hara, M., C. I. Kingsley, M. Niimi, S. Read, S. E. Turvey, A. R. Bushell, P. J. Morris, F. Powrie, and K. J. Wood. 2001. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166: 3789-3796.
48. Graca, L., S. P. Cobbold, and H. Waldmann. 2002. Identification of regulatory T cells in tolerated allografts. J. Exp. Med. 195: 1641-1646.
49. + T cells in protection against CMV disease. Blood 101: 2686-2692.
50. Butcher, E. C., and L. J. Picker. 1996. Lymphocyte homing and homeostasis. Science 272: 60-66.
51. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.